1-12 of 12
glioma, malignant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Health Care Cost Associated with Venous Thromboembolism in Patients with Malignant Glioma

Heather Wright, DO, Chris E. Holmes, MD PhD, Alissa Thomas, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3524.
https://doi.org/10.1182/blood-2018-99-120009
Published: 2018
Journal Articles

Venous Thromboembolism (VTE) Increases the Healthcare Burden in Patients with Malignant Glioma (MG)

Heather Wright, DO, Daniel Douce, MD, Chris E. Holmes, MD PhD, Alissa Thomas, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3364.
https://doi.org/10.1182/blood.V130.Suppl_1.3364.3364
Published: 2017
Journal Articles

Marizomib for CNS-Multiple Myeloma

Ashraf Z Badros, MD, Zeba Singh, MD, Binod Dhakal, MDMS, Young Kwok, MD, Ann MacLaren, PhD, Paul G. Richardson, MD, Mohit Trikha, PhD, Hari Parameswaran, MD
Journal: Blood
Blood (2016) 128 (22): 2118.
https://doi.org/10.1182/blood.V128.22.2118.2118
Published: 2016
Journal Articles

Marizomib Overcomes Compensatory Hyperactivation of Trypsin-like and Caspase-like Subunits to Provide Pan-Proteasome Subunit Inhibition in Patients with Multiple Myeloma and Solid Tumors

Andrew Spencer, Simon Harrison, MD, Francis Burrows, Paul Mainwaring, MD, Timothy Price, MD, Michael J Millward, MD, Peeter Padrik, MD, Craig Underhill, MD, Paul Cannell, MD, Steven D Reich, MD, Mohit Trikha, PhD
Journal: Blood
Blood (2015) 126 (23): 5375.
https://doi.org/10.1182/blood.V126.23.5375.5375
Published: 2015
Journal Articles

Vaccination with WT1 mRNA-Electroporated Dendritic Cells: Report of Clinical Outcome in 66 Cancer Patients

Zwi N. Berneman, Ann L. Van de Velde, Yannick Willemen, Sébastien Anguille, Kirsten Saevels, Paul Germonpré, Manon T. Huizing, Marc Peeters, Annemie Snoeckx, Paul Parizel, Viggo F Van Tendeloo, Eva Lion, Griet Nijs, Barbara Stein, Katrien Vermeulen, Marie-Berthe Maes, Ronald Malfait, Inge Vrelust, Anke Verlinden, Alain P. Gadisseur, Wilfried A Schroyens, Martin Lammens, Evelien L. Smits
Journal: Blood
Blood (2014) 124 (21): 310.
https://doi.org/10.1182/blood.V124.21.310.310
Published: 2014
Journal Articles

The Oligodendrocyte Lineage Transcription Factor 2 (OLIG2) Is Epigenetically Regulated in AML and Suppresses Leukemia Cell Growth

Arzu Yalcin, PhD, Marlon Kovarbasic, Mahmoud Abdelkarim, Gregor Klaus, Julius Wehrle, MD, Verena I. Gaidzik, MD, Heike L Pahl, PhD, Konstanze Doehner, MD, Lars Bullinger, MD PhD, Michael Lübbert, Björn Hackanson, MD
Journal: Blood
Blood (2014) 124 (21): 3540.
https://doi.org/10.1182/blood.V124.21.3540.3540
Published: 2014
Journal Articles

Clinical and Laboratory Risk Factors for Venous Thromboembolism in Patients with High-Grade Gliomas: Results of a Prospective Study of 107 Newly-Diagnosed Patients.

Michael B. Streiff, MD, Xiaobu Ye, MD, Serena Desideri, MD, Thomas Kickler, MD, Jayesh Jani, Stuart Grossman, MD
Journal: Blood
Blood (2008) 112 (11): 1828.
https://doi.org/10.1182/blood.V112.11.1828.1828
Published: 2008
Journal Articles

Methylation Status of Tumor Suppressor Genes BEX2, IGSF4, RARB and TIMP3 Is Indicative for AML with Translocations of the MLL Gene.

Hilmar Quentmeier, PhD, Willy G. Dirks, PhD, Stefan Nagel, PhD, Sonja Röhrs, PhD, Björn Schneider, PhD, Hans G. Drexler, PhD
Journal: Blood
Blood (2007) 110 (11): 2115.
https://doi.org/10.1182/blood.V110.11.2115.2115
Published: 2007
Journal Articles

Glioma Vaccines Generated from Electrofusion of Dendritic Cells and Brain Tumor Stem Cells.

Gregory Plautz, MD, Gene H. Barnett, MD, Cameron Nicholson, MD, Suyu Shu, PhD
Journal: Blood
Blood (2006) 108 (11): 5193.
https://doi.org/10.1182/blood.V108.11.5193.5193
Published: 2006
Journal Articles

“Designer” Cells for Cellular Immunotherapy: Zinc Finger Nuclease (ZFN) Stimulated Targeted Recombination for the Simultaneous Disruption of the Endogenous Glucocorticoid Receptor and Site-Specific Addition of the IL13-Zetakine.

Andreas Reik, PhD, Michael C. Holmes, Ph.D., Fyodor D. Urnov, Ph.D., Yuanyue Zhou, Matthew Mendel, Pei-Qi Liu, Ph.D., Erica Moehle, Edward J. Rebar, Ph.D., Jeffrey C. Miller, Ph.D., Dale Ando, M.D., Philip D. Gregory, Ph.D., Michael Jensen, M.D.
Journal: Blood
Blood (2006) 108 (11): 3705.
https://doi.org/10.1182/blood.V108.11.3705.3705
Published: 2006
Journal Articles

The Identification of Hypercoagulable Markers in Patients with Malignant Gliomas and Venous Thromboembolism.

Rachel P. Rosovsky, MD, Patrick Wen, MD, Santosh Kesari, MD, Elizabeth M. Van Cott, MD, David J. Kuter, MD
Journal: Blood
Blood (2006) 108 (11): 4097.
https://doi.org/10.1182/blood.V108.11.4097.4097
Published: 2006
Journal Articles

Response to High Dose (HD) Imatinib Therapy in Relapsed c-kit+ Acute Myeloid Leukemia (AML).

Edwarda M. Buda, MD, David C. Van Echo, MD, Brendan Weiss, MD, Daniel L. Cruser, MD, Gauri V. Alvarez, MD, Thomas J. Reid, MD, PhD.
Journal: Blood
Blood (2004) 104 (11): 4532.
https://doi.org/10.1182/blood.V104.11.4532.4532
Published: 2004